Alterity Therapeutics Ltd.ASX: ATH

New data show potential for PBT434 to treat MSA

Oct 5, 2018 at 4:46 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment